会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • 옥사다이아졸 유래아 유도체, 이의 제조방법 및 이를유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물
    • 奥沙利多尿素衍生物,制备方法和用于预防和治疗癌症的药物组合物
    • KR100800437B1
    • 2008-02-01
    • KR1020060079562
    • 2006-08-22
    • 한국생명공학연구원
    • 권병목한동초손광희신대섭이지민
    • C07D271/08A61K31/553A61P35/00
    • An oxadiazole urea having a novel structure is provided to inhibit the growth of cancer cells by effectively controlling mitosis in a cell cycle, thereby being usefully used for preventing and treating cancers. A oxadiazole urea derivative is represented by the formula(1), where R is C1-5 alkyl or C1-5 alkyl carbonyl. A method for preparing the derivative or a pharmaceutically acceptable salt thereof comprises the steps of: (a) after reacting a substituted benzealdehyde compound represented by the formula(2) with N-chlorosuccinimide(NCS), reacting a reaction product with potassium cyanide to prepare a cyano compound represented by the formula(3); (b) after reacting the compound of the formula(3) with amino hydroxide, treating the reaction product with a base solution to prepare an oxadiazole compound represented by the formula(4); (c) reacting the compound of the formula(4) with 4-trifluoromethylaniline and triphosgene to prepare an oxadiazole urea compound represented by the formula(5); and (d) reacting the compound of the formula(5) with alkyl halide or alkyl carbonyl halide to prepare an oxadiazole urea derivative represented by the formula(1). A pharmaceutical composition for preventing and treating large intestine cancer or breast cancer comprises the oxadiazole urea derivative or a pharmaceutically acceptable salt thereof as an effective ingredient.
    • 提供具有新结构的恶二唑尿素,通过有效地控制细胞周期中的有丝分裂来抑制癌细胞的生长,从而有效地用于预防和治疗癌症。 恶二唑脲衍生物由式(1)表示,其中R是C 1-5烷基或C 1-5烷基羰基。 制备衍生物或其药学上可接受的盐的方法包括以下步骤:(a)使由式(2)表示的取代苯醛化合物与N-氯代琥珀酰亚胺(NCS)反应后,使反应产物与氰化钾反应以制备 由式(3)表示的氰基化合物; (b)使式(3)的化合物与氨基氢氧化物反应后,用碱溶液处理反应产物,制备由式(4)表示的恶二唑化合物; (c)使式(4)的化合物与4-三氟甲基苯胺和三光气反应,制备由式(5)表示的恶二唑脲化合物。 和(d)使式(5)的化合物与烷基卤或烷基羰基卤反应,制备由式(1)表示的恶二唑脲衍生物。 用于预防和治疗大肠癌或乳腺癌的药物组合物包含恶二唑脲衍生物或其药学上可接受的盐作为有效成分。
    • 7. 发明公开
    • 항불안 활성을 갖는 오보바톨을 함유하는 조성물
    • 包含具有抗炎活性的OBOVATOL的组合物
    • KR1020060115454A
    • 2006-11-09
    • KR1020050037854
    • 2005-05-06
    • 충북대학교 산학협력단한국생명공학연구원
    • 홍진태이승호권병목손광희서정주오기완
    • A61K31/085A61K31/05
    • A61K31/085
    • A composition comprising obovatol having anti-anxiety activity is provided to prevent and treat anxiety associated with brain nerve system disorder without side effects such as sleeper effect. The composition for preventing and treating anxiety associated with brain nerve system disorder comprises obovatol represented by the formula(1), and pharmaceutically acceptable carriers, diluents or excipients, wherein the anxiety associated with brain nerve system disorder is panic disorder, obsessive-compulsive disorder, stress disorder, social anxiety and generalized anxiety disorder; the composition is formulated as pharmaceutical composition or health food; and the health food is formulated as pill, powder, granule, liquid, tablet, capsule or drink.
    • 提供了包含具有抗焦虑活性的咯波酚的组合物,以预防和治疗与脑神经系统障碍相关的焦虑,而不会产生诸如睡眠效应的副作用。 用于预防和治疗与脑神经系统疾病相关的焦虑的组合物包括由式(1)表示的咯博醇和药学上可接受的载体,稀释剂或赋形剂,其中与脑神经系统疾病相关的焦虑是恐慌症,强迫症, 压力障碍,社会焦虑和广泛性焦虑症; 该组合物配制成药物组合物或保健食品; 保健食品配制成丸剂,粉剂,颗粒剂,液体,片剂,胶囊或饮料。